Arcutis Biotherapeutics Cash Flow Statement (2019-2026) | ARQT

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-57.06M-71.64M-65.23M-68.06M-107.71M-72.02M-80.10M-70.99M-44.77M-66.28M-35.38M-52.33M-41.54M-10.79M-25.06M-15.89M7.41M17.37M-11.29M15.01M
Depreciation and Depletion (Quarter)
0.12M0.18M0.15M0.15M0.16M0.16M0.17M0.20M0.20M0.23M0.17M0.16M0.16M0.10M0.15M
Share-based Compensation (Quarter)
5.36M5.69M6.53M8.10M8.79M9.26M9.48M10.58M10.00M-30.06M10.03M12.52M9.78M-32.34M9.78M10.49M-17.41M10.69M12.76M
Cash from Operations (Quarter)
-40.88M-51.71M-56.98M-61.98M-67.69M-71.06M-80.34M-66.48M-43.98M-56.24M-31.60M-45.12M-34.69M-0.75M-30.38M0.32M-1.75M26.18M2.24M12.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-1.15M-0.89M-0.62M-0.27M0.80M2.34M2.16M1.82M1.53M1.47M1.73M2.39M1.69M1.10M0.86M0.69M0.55M-0.01M0.18M0.22M
Amortization of Deferred Charges (Quarter)
0.08M0.07M0.08M0.08M0.08M0.08M0.09M0.09M0.09M0.09M0.10M0.10M0.10M0.11M0.11M
Depreciation & Amortization (CF) (Quarter)
0.12M0.18M0.15M0.15M0.16M0.16M0.17M0.20M0.20M0.23M0.17M0.16M0.16M0.10M0.15M
Change in Working Capital
Change in Receivables (Quarter)
2.43M6.03M4.31M4.44M2.21M6.39M11.35M5.18M16.61M14.13M12.35M21.27M8.43M31.11M-1.85M10.79M
Change in Inventory (Quarter)
4.31M3.21M1.04M1.92M3.44M-0.78M0.11M0.63M-0.61M0.27M1.95M-0.52M5.89M0.01M14.58M1.18M
Change in Account Payables (Quarter)
2.24M2.39M5.20M-4.03M0.22M0.18M3.38M4.94M-3.97M-1.19M0.99M-5.16M6.51M-0.10M0.31M0.55M-9.29M6.73M5.61M-11.54M
Change in Accured Expenses (Quarter)
3.37M11.68M-5.53M-1.51M7.62M0.62M-4.46M-5.07M9.20M5.92M-0.33M9.06M10.12M13.18M-0.21M21.23M5.57M23.45M20.77M9.96M
Other Working Capital Changes (Quarter)
-3.69M-5.87M-0.09M-1.97M1.78M-0.15M2.42M-2.74M-0.17M9.11M-5.54M2.17M4.25M0.07M-0.20M-0.20M1.15M-1.42M-0.14M2.55M
Investing Activities
Capital Expenditures (Quarter)
0.14M0.26M0.12M0.08M0.01M0.12M0.08M0.28M0.06M0.01M0.14M0.61M0.08M0.16M
Change in Acquisitions & Divestments (Quarter)
36.00M72.00M70.92M132.89M67.25M80.41M147.50M135.00M68.00M56.00M77.25M63.64M90.61M57.28M68.47M60.65M43.30M55.00M50.82M50.52M
Cash from Investing Activities (Quarter)
3.47M23.50M15.30M52.56M-197.26M42.20M107.75M89.12M45.55M-62.19M-28.70M-62.14M84.78M34.88M11.75M17.42M-25.25M-34.18M-11.33M-15.22M
Financing Activities
Other financing activities (Quarter)
0.62M0.17M0.26M0.71M0.02M0.02M0.10M0.07M0.87M0.21M0.08M0.57M1.06M0.40M0.06M0.86M3.28M1.07M1.36M
Cash from Financing Activities (Quarter)
0.06M72.88M14.72M1.13M284.99M0.96M0.10M1.07M0.87M99.29M161.76M1.46M0.39M-97.41M0.40M1.38M1.48M3.72M1.07M1.99M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
14.50M-0.04M3.10M161.68M3.10M
Additional items
Exchange Rate Effect (Quarter)
-0.05M0.01M-0.07M0.07M-0.07M-0.03M0.10M-0.23M0.00M0.20M-0.10M0.06M-0.12M-0.05M
Change in Cash (Quarter)
-37.35M44.67M-26.96M-8.28M20.03M-27.90M27.45M23.71M2.36M-19.07M101.39M-105.83M50.58M-63.52M-18.23M19.33M-25.62M-4.21M-8.14M-0.64M
Free Cash Flow (Quarter)
-41.02M-51.97M-57.10M-62.06M-67.70M-71.19M-80.43M-66.76M-44.05M-56.25M-31.60M-45.12M-34.83M-0.75M-30.99M0.25M-1.75M26.18M2.08M12.64M
Net Cash Flow (Quarter)
-37.35M44.67M-26.96M-8.28M20.03M-27.90M27.51M23.70M2.43M-19.14M101.46M-105.80M50.48M-63.28M-18.23M19.13M-25.52M-4.27M-8.03M-0.59M